Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Return on Assets (ROA)
since 2019

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Shockwave Medical Inc., ROA, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 US$ in thousands


Net Income (Loss)
The net income experienced a significant fluctuation over the analyzed period. Initially, the company reported substantial losses, with the loss increasing from approximately -51.1 million USD in 2019 to about -65.7 million USD in 2020. In 2021, the loss sharply decreased to around -9.1 million USD, indicating an improvement. A notable turnaround occurred in 2022, achieving a positive net income of approximately 216.0 million USD. However, in 2023, the net income declined to roughly 147.3 million USD, which, while lower than 2022, remains substantially positive compared to previous years.
Total Assets
The total assets increased continuously during the period of 2019 to 2023. Starting at around 231.9 million USD in 2019, assets grew steadily each year, reaching approximately 272.0 million USD in 2020, 345.7 million USD in 2021, and then more than doubling in 2022 to roughly 646.1 million USD. This growth trend accelerated dramatically by 2023, with total assets surpassing 1.56 billion USD, indicating significant asset accumulation or investment growth.
Return on Assets (ROA)
ROA followed a trajectory correlated with net income but shows distinct volatility. It was deeply negative in 2019 and 2020, at -22.04% and -24.15% respectively, reflecting substantial losses relative to assets. In 2021, ROA improved significantly to -2.64%, signaling a move toward profitability. A sharp positive reversal occurred in 2022 with ROA reaching 33.43%, aligning with the recorded net income profit. In 2023, ROA decreased to 9.4%, indicating a reduction in asset profitability but still maintaining a positive return position.

Comparison to Competitors

Shockwave Medical Inc., ROA, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Comparison to Sector (Health Care Equipment & Services)

Shockwave Medical Inc., ROA, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Comparison to Industry (Health Care)

Shockwave Medical Inc., ROA, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).